Skip to content

Improvement of a Digital Health Platform for Remote Monitoring of Patients With Heart Failure

Observational Study for the Improvement of a Digital Health Platform for Remote Monitoring of Patients With Heart Failure

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05708846
Acronym
DHEART
Enrollment
154
Registered
2023-02-01
Start date
2023-05-18
Completion date
2024-12-31
Last updated
2025-04-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Heart Failure

Keywords

Heart Failure, Telemonitoring, Remote monitoring, Remote care, Healthcare, Home care, Artificial Intelligence, Chronic patients

Brief summary

In the present project, we propose to run an observational study in order to create a huge dataset with telemonitoring data from heart failure (HF) patients. The dataset will contain physiological measurements, socio-demographic data, risk factor information, medication tracking, symptomatology, clinical events and health-related questionnaire answers from each patient. Furthermore, health-related alarms will be delivered to the medical professionals whenever a measure from a patient is out of a predefined clinical range. These alarms and its defined level of relevance (indicated by the medical professionals) will also be Included in the dataset. With the annotated dataset we will be able to implement and train Machine Learning (ML) models that will improve the alarm-based system by making it more robust, trustworthy and reliable.

Detailed description

Heart Failure (HF) is a prevalent and fatal clinical syndrome that affects the quality of life of millions of people worldwide. Between 17% and 45% of patients suffering from HF die within the first year and the remaining die within 5 years. Furthermore, those patients have a high risk of rehospitalization, their associated healthcare costs are huge, and the higher the life expectancy, the higher the disease's prevalence. HF symptoms commonly include shortness of breath, excessive tiredness, and leg swelling which may be worsened with decompensation, and thus displacement to medical centers represents a handicap for such individuals. Remote monitoring technologies provide a feasible solution that allows earlier decompensation identification and better adherence to lifestyle changes and medication. Although telemonitoring by smartphones showed the potential to reduce both the frequency and the duration of HF hospitalizations, there was no association with the reduction of all-cause mortality. Thus, it indicates there is a need to look for more effective and precise methodologies. In recent years, the use of wearable devices that allow daily monitoring of patient's physiological data combined with Artificial Intelligence (AI) has shown immense potential in predicting cardiovascular-related diseases, their adverse events and patient's health status, including that of patients with HF. Vitalera has implemented a cloud platform and an alarm-based system for remote monitoring of patients that delivers health alarms when a patient's biomedical measurement is out of a predefined range. The platform relieves clinicians and caretakers of going through each patient's data to check for anomalies, accelerating the decision-making process and reducing hospital consultations. However, the system is creating many straightforward alarms that are finally being discarded after evaluation by the medical professional. In the present project, we propose to run an observational study in order to create a huge dataset with patients' clinical data that will contain annotations regarding the relevance of each alarm. With the annotated dataset we will be able to implement and train Machine Learning (ML) models that will improve the remote monitoring system and its alarm-based system by making it more robust, trustworthy and reliable. This study is being conducted in the framework of a European project promoted by the European Innovation Council (EIC). An earlier version of the platform was validated in a study conducted in 2020 at Hospital de Torrevieja focused on HF. The rationale for this study is in line with vitalera's goal of incorporating artificial intelligence tools to optimize the digital platform. While this study is focused on the creation of a diverse and labeled dataset and on the development of artificial intelligence event-prediction algorithms, a forthcoming second study will focus on the validation of the algorithms to assess their clinical effectiveness. This is an observational study involving a European network of hospitals. The study consists of continuous remote patient monitoring using vitalera's digital platform and the supplied devices (tensiometer, wearable, scale and oximeter). For 6 months, a total of 500 patients suffering from HF will have their physiological constants monitored. Patients will be included in the study based on the eligibility criteria and must complete the informed consent provided. Each hospital will decide when to include their patients according to their particular clinical practice (either in the process of discharge planning or during the first follow-up visit, i.e.. 1 or 2 weeks after discharge). The recruitment period is defined as 6 months. That means patients will be incorporated into the study from its start until the sixth month. The last subject included in the study will then finish the study after one year from the first day of the study. Medical professionals from each hospital will be in charge of recruiting the participants. The recruitment rate is specific for each hospital, and it may vary depending on the month. There is no power calculation associated with the study since the main objective of the study is to gather a dataset in order to train ML models. Once the algorithms are developed, model performance in terms of accuracy will be evaluated by means of C statistic, the area under the receiver operating characteristic curve, and creation of a calibration plot. Furthermore, the models will be evaluated in terms of fairness and potential bias using metrics including statistical parity, group fairness, equalized odds and predictive equality.

Interventions

OTHERTelemonitoring

All patients will be telemonitored in order to create a labeled and diverse dataset that will include the following data: Physiological parameters (measured periodically), socio-demographic data, risk factors, medication tracking, symptomatology questionnaire for patients, NYHA-class, clinical interventions, health questionnaire answers, classified alarms with their respective timestamp and annotation by the MD, and measurement ranges for each personalized alarm and their changes

Sponsors

European Innovation Council
CollaboratorOTHER
Hospital Universitario de Torrevieja
CollaboratorUNKNOWN
University of Barcelona
CollaboratorOTHER
humanITcare
Lead SponsorNETWORK

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Heart failure (HF) patients with NYHA Functional Class \>= II (according to 2021 EU guidelines). * Patients older than 18 years old. * Patients who have suffered an acute decompensation of HF (first and recurrent) in the 30 days prior to enrollment in the study. * NT-pro BNP ≥300 pg/ml at the moment of hospitalization for patients without ongoing atrial fibrillation/flutter. If ongoing atrial fibrillation/flutter, NT-pro BNP must be ≥600 pg/mL * Patients must have had an echocardiogram during their HF hospitalization or in the previous 12 months. * Prior to initiating any procedures, the hospital will ensure that the patient obtains an informed consent document, if applicable. * All patients will be eligible regardless of the level of LVEF: HFrEF, HFmrEF, and HFpEF.

Exclusion criteria

* Oncology patients with metastasis or with chemotherapy treatment ongoing * Patients participating in other studies or trials. * Patients not willing to participate. * Patients over 150 kg * Patients who do not use Catalan, Spanish, English, Portuguese, Italian, Dutch, German, Swedish, Hungarian, Romanian or French. * Patients without a mobile phone * Patients without internet connexion * Patients with moderate or severe cognitive impairment without a competent caregiver * Patients with serious psychiatric illness * Patients with planned cardiac surgery * Patients with planned heart transplantation or LVAD implant

Design outcomes

Primary

MeasureTime frameDescription
Number of Patients Included in the Dataset6 monthsThe dataset will contain the data from HF patients being telemonitored. This outcome shows the number of patients from which data will be used to build a dataset to train ML models for patient health prediction.
Implement ML Models to Improve the Current Alarm-based System Using the Dataset Created6 monthsThe models should: Provide a relevance level for each new alarm by reducing the number of irrelevant alarms and thus fostering personalized follow-up. Be robust across different new hospitals and reliable and fair across different target populations, considering the diverse sociodemographic data that will be available in the dataset.

Secondary

MeasureTime frameDescription
Track All Clinical Interventions and Events to be Included in the Database6 monthsWith the registered information, develop and implement ML event prediction algorithms that will add new self-generated alarms to the system. These alarms should forecast: Untracked hospital interventions, such as UCI visits or hospital readmissions. Changes of medication with their particular estimated dose. Clinical events, such as mortality.
Assess Patient and Medical Professional Satisfaction With the Digital Platform6 monthsAssess patient and medical professional satisfaction with the digital platform at the study's end by using the Post-Study Usability Questionnaire (PSSUQ).
Mean SUS Score to Assess the Usability of the Digital Platform App6 monthsAssess the usability of the digital platform at the end of the study by means of the System Usability Scale (SUS). The SUS is a standardized tool used to evaluate the usability of digital platforms through a 10-item questionnaire. Each item is rated on a 5-point Likert scale, ranging from Strongly Disagree (1) to Strongly Agree (5). Scale from 0 to 100. The higher the score the better usablity.

Countries

Romania, Spain

Participant flow

Participants by arm

ArmCount
Telemonitored Heart Failure Patients
All patients in the observational study will be telemonitored following the same protocol.
134
Total134

Withdrawals & dropouts

PeriodReasonFG000
Overall StudyDeath5
Overall StudyWithdrawal by Subject20

Baseline characteristics

CharacteristicTelemonitored Heart Failure Patients
Age, Continuous68 years
STANDARD_DEVIATION 14
Alcohol use
No
42 Participants
Alcohol use
Yes
21 Participants
Alcohol use
Yes, occasionally
71 Participants
Diabetes
No
93 Participants
Diabetes
Yes
41 Participants
Education level
High
45 Participants
Education level
Primary
32 Participants
Education level
Secondary
37 Participants
Education level
Without education
20 Participants
Employment status
None
4 Participants
Employment status
Paid
32 Participants
Employment status
Retired
94 Participants
Employment status
Unemployed
3 Participants
Employment status
Voluntary
1 Participants
History of heart disease
No
48 Participants
History of heart disease
Yes
86 Participants
Hypertension
No
31 Participants
Hypertension
Yes
103 Participants
Level of Ejection Fraction (LVEF)
<40
87 Participants
Level of Ejection Fraction (LVEF)
40-50
21 Participants
Level of Ejection Fraction (LVEF)
>=50
26 Participants
Number of people living with the patient2 people
STANDARD_DEVIATION 1
NYHA class
II
94 Participants
NYHA class
III
36 Participants
NYHA class
IV
4 Participants
Race/Ethnicity, Customized
Ethnicity:
Latino
2 Participants
Race/Ethnicity, Customized
Ethnicity:
White
132 Participants
Sex: Female, Male
Female
38 Participants
Sex: Female, Male
Male
96 Participants
Smoker
Ex-smoker
48 Participants
Smoker
No
59 Participants
Smoker
Yes
27 Participants
The patient has a caretaker?
No
73 Participants
The patient has a caretaker?
Yes
61 Participants

Adverse events

Event typeEG000
affected / at risk
deaths
Total, all-cause mortality
5 / 134
other
Total, other adverse events
3 / 134
serious
Total, serious adverse events
18 / 134

Outcome results

Primary

Implement ML Models to Improve the Current Alarm-based System Using the Dataset Created

The models should: Provide a relevance level for each new alarm by reducing the number of irrelevant alarms and thus fostering personalized follow-up. Be robust across different new hospitals and reliable and fair across different target populations, considering the diverse sociodemographic data that will be available in the dataset.

Time frame: 6 months

Primary

Number of Patients Included in the Dataset

The dataset will contain the data from HF patients being telemonitored. This outcome shows the number of patients from which data will be used to build a dataset to train ML models for patient health prediction.

Time frame: 6 months

Population: All enrolled patients, except the withdrawn ones, are included in the dataset to train ML models.

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
Telemonitored Heart Failure PatientsNumber of Patients Included in the Dataset134 Participants
Secondary

Assess Patient and Medical Professional Satisfaction With the Digital Platform

Assess patient and medical professional satisfaction with the digital platform at the study's end by using the Post-Study Usability Questionnaire (PSSUQ).

Time frame: 6 months

Secondary

Mean SUS Score to Assess the Usability of the Digital Platform App

Assess the usability of the digital platform at the end of the study by means of the System Usability Scale (SUS). The SUS is a standardized tool used to evaluate the usability of digital platforms through a 10-item questionnaire. Each item is rated on a 5-point Likert scale, ranging from Strongly Disagree (1) to Strongly Agree (5). Scale from 0 to 100. The higher the score the better usablity.

Time frame: 6 months

Population: We show the results of the SUS score for the patients that answered the questionnaire

ArmMeasureValue (MEAN)Dispersion
Telemonitored Heart Failure PatientsMean SUS Score to Assess the Usability of the Digital Platform App69.83 score on a scaleStandard Deviation 17.97
Secondary

Track All Clinical Interventions and Events to be Included in the Database

With the registered information, develop and implement ML event prediction algorithms that will add new self-generated alarms to the system. These alarms should forecast: Untracked hospital interventions, such as UCI visits or hospital readmissions. Changes of medication with their particular estimated dose. Clinical events, such as mortality.

Time frame: 6 months

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026